Charles-Antoine Morand
Founder & CEO @ Karot Capital
Paris, France
Charles-Antoine Morand is a Series A investor at Karot Capital in Paris focused on Medical Device and Robotics. Charles-Antoine has been working as a VC and private equity specialist since 1999, investing in companies such as Medtech Surgical (Sold to Zimmer), Mobpartner (sold to Cheetah Mobile), Calendra (sold to BMC Softwrae), Highdela (sold to SAP) Charles-Antoine started his career as an auditor at Arthur Andersen.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Charles-Antoine Morand invests in
Stages Charles-Antoine Morand invests in
Countries Charles-Antoine Morand invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Medical Device 2 (67%)
- Robotics 1 (33%)
- Health Care 1 (33%)
Stage
- Series A 2 (67%)
- Seed 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Archeon is fully dedicated to the development of innovative solutions for the monitoring, diagnosis and treatment of critically ill patients in prehospital care. | $6.1M / Series A / Mar 16, 2022 | ||
| bem.builders provides promote and advertise the projects, monitor innovation and share with communities, monitor technological, blockchain, dual virtual, events, and leveraging services. | $2.3M / Seed / Feb 14, 2022 | ||
| Medtech’s mission statement can be summarized in the following way: Their mission consists of the broader use of medical technology for the benefit of both patient and practitioner as they strive for improved overall health and well-being.Medtech designs, develops and markets a new generation of robotic assistance for the express purpose ofimproved surgical techniques. Their robots contribute to safer and more stable implementation of both more effective and less invasive treatment. | $1.6M / Series A / Apr 23, 2010 |
Co-Investors
About Karot Capital
Karot Capitalis an innovation-driven VC that will focus on investments of €300k to €2m in Seed and Series A rounds. Karot Capital will target companies with a finalized product/service generating early sales.
Karot Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Charles-Antoine Morand
Founder & CEO
|
|||
Erez Ofer
Investor
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Charles-Antoine Morand invest in?
Charles-Antoine Morand invests primarily in Medical Device, Robotics and Health Care startups, most often at Series A and Seed stage. Most of the 3 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Charles-Antoine Morand?
Public channels for Charles-Antoine Morand include LinkedIn and X (Twitter). For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Charles-Antoine Morand last invest?
The most recent investment recorded for Charles-Antoine Morand closed in Mar 2022. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
